Expert US stock analyst coverage consensus and rating distribution analysis to understand market sentiment. We aggregate analyst opinions to provide a consensus view of Wall Street expectations for any stock.
Johnson & Johnson (NYSE: JNJ), the diversified global healthcare leader operating across pharmaceuticals, medical technology, and consumer health with leading treatments in immunology, oncology, neuroscience and cardiovascular care, has emerged as a top deep-value play amid a broad 2026 selloff in t
Johnson & Johnson (JNJ) β Undervalued Pharma Leader Offers Defensive Upside Amid Sector Selloff, Jim Cramer Backs Staggered Entry - Professional Trade Ideas
JNJ - Stock Analysis
4771 Comments
1933 Likes
1
Moniesha
Regular Reader
2 hours ago
Regret missing this earlier. π
π 150
Reply
2
Amarr
Power User
5 hours ago
I feel like I need a discussion group.
π 108
Reply
3
Breandrea
Engaged Reader
1 day ago
Comprehensive US stock earnings whisper numbers and actual versus estimate analysis to identify surprises before they happen. Our earnings surprise analysis helps you anticipate positive or negative reactions before the market opens.
π 81
Reply
4
Classie
Trusted Reader
1 day ago
Market breadth is positive, indicating healthy participation.
π 126
Reply
5
Jameire
Loyal User
2 days ago
Free US stock insider buying and selling tracking with regulatory filing analysis for inside information on company health. We monitor corporate insider transactions because company officers often have the best understanding of their business prospects.
π 235
Reply
© 2026 Market Analysis. All data is for informational purposes only.